Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q2 2023 Earnings Call Transcript

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q2 2023 Earnings Call Transcript August 8, 2023

Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.74, expectations were $0.63.

Operator: Good afternoon, my name is Chris and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Halozyme Second Quarter 2023 Financial and Operating Results Conference Call. After the speaker’s remarks, there will be a question-and-answer session. [Operator...